News & Analysis as of


Clinical trials: Digital technology for recruitment, consent, and data capture

by Hogan Lovells on

The conduct of clinical trials still relies heavily on the use of paper documents. Of course, electronic case report forms (eCRF) have been commonly used for many years – the medical information on a patient that is...more

The PTAB Review - March 2018

Challenges to Immunology Patents Lead Increase in Biotechnology Cases at the PTAB in 2017 - Throughout the history of inter partes review (IPR) proceedings, petitions have been dominated by challenges to patents directed...more

New listing regime proposals for emerging and innovative companies

by Hogan Lovells on

On 23 February 2018, the Stock Exchange of Hong Kong Limited (the "HKEx") published a consultation paper seeking public comments on Listing Rules amendments aimed at expanding the listing regime to help list companies from...more

Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

by Jones Day on

The Hong Kong Stock Exchange recently published a Consultation Paper on a Listing Regime for Companies from Emerging and Innovative Sectors, and proposed to introduce a new chapter implementing the listing of...more

FDA Clears New Surgery Infection Control System

by Knobbe Martens on

The FDA recently cleared Prescient Surgical’s CleanCisionTM Wound Retraction and Protection System (CleanCisionTM), a retractable device designed to prevent surgical site infection. According to Prescient Surgical,...more

Digital Health and Personalized Medicine: Part I – Recent Acquisitions

by Knobbe Martens on

Throughout the past year, substantial investment continued to pour into digital health and personalized medicine. Personalized medicine involves the discovery of particular genetic variations that contribute to human...more

Wright Medical Group N.V. announces $88 million Acquisition of IMASCAP SAS

by Knobbe Martens on

Wright Medical Group recently announced the acquisition of IMASCAP SAS for $88 million. According to the press release, Wright Medical Group (NASDAQ: WMGI) is a publicly traded company focusing on extremity joint replacement...more

Hong Kong Announces Groundbreaking New Rules for Dual-Class Share, High-Tech and Biotech Company Listings

After publishing the “New Board Concept Paper Conclusions” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued on 23 February 2018 a consultation paper entitled “A Listing Regime for Companies From...more

Bridgestone, Versalis Partner To Develop Technology To Commercialize Guayule

by Bergeson & Campbell, P.C. on

On February 12, 2018, Bridgestone Americas (Bridgestone) announced a strategic partnership with Versalis, a producer of polymers and elastomers, to develop a comprehensive technology package to commercialize guayule in the...more

AkzoNobel Announces Project Development Agreement For Waste-To-Chemical Facility

by Bergeson & Campbell, P.C. on

On February 16, 2018, AkzoNobel, a member of the Biobased and Renewable Products Advocacy Group (BRAG®), announced that a consortium of companies signed a project development agreement to develop a waste-to-chemistry facility...more

Seattle Genetics Acquires Cascadian Therapeutics, Continuing a Strong 2018 Start in Biotech Mergers and Acquisitions

by Knobbe Martens on

On January 31, two Seattle biotech companies, Seattle Genetics and Cascadian Therapeutics, announced a merger agreement under which Seattle Genetics will acquire Cascadian Therapeutics for $614 million. The announcement...more

Da Volterra Develops Device to Combat Antibiotic Resistance

by Knobbe Martens on

Da Volterra, a biotech company developing products in the antibacterial field, has announced results in a human clinical trial for DAV132, a product said to prevent life-treating bacterial infections during antibiotic...more

DOE National Lab Develops Supertough Bioplastic

by Bergeson & Campbell, P.C. on

Researchers at Oak Ridge National Laboratory (ORNL) announced the development of a method to create a supertough renewable plastic with improved manufacturability. The method involved the addition of a small amount of...more

Advanced Bioeconomy Leadership Conference February 28 - March 2, 2018, Washington D.C.

by Bergeson & Campbell, P.C. on

The Advanced Bioeconomy Leadership Conference 2018 (ABLC) will be held February 28 - March 2, 2018, at the Mayflower Hotel in Washington, D.C. ABLC is the gathering point for top leaders in the Advanced Bioeconomy --...more

Passage of Federal Right-to-Try law poses risks and opportunities for patients and the biopharmaceutical industry

by Hogan Lovells on

Right-to-try laws and the future of access to investigational treatments - The treatment of patients with unapproved therapies is often referred to as “compassionate use” or “expanded access”. Under right-to-try laws,...more

Alberta Innovates, Silvacom Launch BRIMS To Support Alberta’s Bioeconomy

On January 25, 2018, Alberta Innovates announced the launch of the Bio-Resource Information Management System (BRIMS), which was developed in conjunction with Silvacom Ltd. BRIMS is a publicly available data and information...more

Section 9003 Biorefinery and Renewable Chemical Loan Program Gains Momentum - USDA Program Proves to Be Viable Commercialization...

by Holland & Knight LLP on

• The U.S. Department of Agriculture's 9003 Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program (Section 9003 Program) had an unprecedented year in 2017, issuing numerous conditional...more

JPM Conference Takeaways: Biotech and Biopharma Set for Growth in 2018

Coming off a year that saw a record number of new drug approvals, significant scientific breakthroughs and a year-end tax reform package that both significantly lowers corporate taxes and provides the long-awaited tax...more

Tried and trusted: US M&A in 2017: Searching for the next big thing: Healthcare M&A

by White & Case LLP on

The hunt for blockbuster drugs is driving activity within the sector, while technology firms’ increasing presence in the market will be an area to watch in 2018. Despite a fall in headline figures, the healthcare sector...more

In re Janssen Biotech, Inc. (Fed. Cir. 2018)

Last week, the Federal Circuit affirmed the rejection by the U.S. Patent and Trademark Office's Patent Trial and Appeal Board of claims 1-7 of U.S. Patent No. 6,284,471 as being unpatentable under the doctrine of...more

AkzoNobel Launches 2018 Imagine Chemistry Challenge

by Bergeson & Campbell, P.C. on

On January 10, 2018, AkzoNobel, a member of the Biobased and Renewable Products Advocacy Group (BRAG®), announced the challenges for its latest Imagine Chemistry program. AkzoNobel initiated the Imagine Chemistry program in...more

Advanced Bioeconomy Leadership Conference February 28 - March 2, 2018, Washington D.C.

by Bergeson & Campbell, P.C. on

The Advanced Bioeconomy Leadership Conference 2018 (ABLC) will be held February 28 - March 2, 2018, at the Mayflower Hotel in Washington, D.C. ABLC is the gathering point for top leaders in the Advanced Bioeconomy --...more

Rural Prosperity Task Force Presents Findings To President Trump

by Bergeson & Campbell, P.C. on

On January 8, 2018, U.S. Secretary of Agriculture Sonny Perdue presented to President Donald Trump the findings of the Interagency Task Force on Agriculture and Rural Prosperity. The Task Force was established in 2017...more

2017 – It was biotech and pharma who kept the Australian legal system busy

by FPA Patent Attorneys on

2016 saw the Australian legal system deal with the questions that ranged from defining a human being to defining an inventor. 2017 proved to be just as interesting, and just as informative for patentees and applicants as to...more

Clariant, Global Bioenergies Announce New Biobased Polymer For Cosmetics

by Bergeson & Campbell, P.C. on

On January 2, 2018, Clariant, a specialty chemicals company, announced the development of a new biobased polymer for cosmetic creams and lotions. The new ingredient is a rheology modifier that influences formulation...more

704 Results
View per page
Page: of 29

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.